Indian Journal of Gastroenterology

, Volume 33, Issue 6, pp 564–567 | Cite as

Olmesartan-related sprue-like enteropathy

  • Naresh Bhat
  • N. K. Anupama
  • Amit Yelsangikar
  • Kayal Vizhi
Case Series


Chronic diarrhea is a common clinical problem in gastroenterology practice and often difficult to diagnose the cause. Presence of villous atrophy in these subjects is not specific as differential diagnosis can be broad. Drug-induced diarrhea is often overlooked during the evaluation. We report a short series of such challenging small bowel diarrhea secondary to olmesartan-related sprue-like enteropathy.


Celiac Diarrhea Enteropathy Olmesartan Sprue 


Conflict of interest

NB, ANK, AY, and KV all declare that they have no conflicts of interest.

Ethics statement

The study was performed in a manner to conform with the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning Human and Animal Rights and the authors followed the policy concerning Informed Consent as shown on


  1. 1.
    Farrell RJ, Kelly CP. Celiac sprue and refractory sprue. In: Farrell RJ, Kelly CP, editors. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease, 9th edition. Philadelphia: Saunders- Elsevier; 2010. p. 1797–820.Google Scholar
  2. 2.
    De Gaetani M, Tennyson CA, Lebwohl B, et al. Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol. 2013;108:647–53.CrossRefGoogle Scholar
  3. 3.
    Ludvigsson JF, Brandt L, Montgomery SM, et al. Validation of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterol. 2009;9:19.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Zielger TR, Fernandez-Estivariz C, Gu LH, et al. Severe villous trophy and chronic malabsorption induced by azathioprine. Gastroenterology. 2003;124:1950–7.CrossRefGoogle Scholar
  5. 5.
    Kamar N, Faure P, Dupuis E, et al. Villous atrophy induced by mycophenolate mofetil in renal-transplant patients. Transpl Int. 2004;17:463–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Weclawiak H, Ould-Mohamed A, Bournet B, et al. Duodenal villous atrophy after solid-organ transplantation. Am J Transplant. 2011;11:575–82.PubMedCrossRefGoogle Scholar
  7. 7.
    Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe sprue like enteropathy associated with Olmesartan. Mayo Clin Proc. 2012;87:732–8.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Nielson JA, Steephen A, Lewin M. Angiotensin–II inhibitor (olmesartan) induced collagenous sprue with resolution following discontinuation of drug. World J Gastroenterol. 2013;19:6928–30.CrossRefGoogle Scholar
  9. 9.
    Ianiro G, Bibbo S, Montalto M, et al. Systematic review: sprue like enteropathy associated with olmesartan. Aliment Pharmacol Ther. 2014;40:16–23.PubMedCrossRefGoogle Scholar

Copyright information

© Indian Society of Gastroenterology 2014

Authors and Affiliations

  • Naresh Bhat
    • 1
  • N. K. Anupama
    • 1
  • Amit Yelsangikar
    • 1
  • Kayal Vizhi
    • 1
  1. 1.Department of GastroenterologyColumbia Asia Referral HospitalBangaloreIndia

Personalised recommendations